Blacher Joshua purchased $26K of BFRG
Blacher Joshua (Chief Financial Officer) purchased 50,000 shares of BullFrog AI Holdings, Inc. (BFRG) at $0.53 on 2026-09-22.
BullFrog AI Holdings, Inc.
No enriched coverage for $BFRG in the last 7 days.
Blacher Joshua (Chief Financial Officer) purchased 50,000 shares of BullFrog AI Holdings, Inc. (BFRG) at $0.53 on 2026-09-22.
Singh Vininder (Chief Executive Officer) purchased 75,000 shares of BullFrog AI Holdings, Inc. (BFRG) at $0.60 on 2026-09-22.
BullFrog AI Holdings, Inc. (BFRG) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. false 0001829247 0001829247 2026-06-11 2026-06-11 0001829247 BFRG:CommonStockParValue0.00001Member 2026-06-11 2026-06-11 0001829247 BFRG:TradeableWarrantsMember 2026-06-11 2026-06-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSIO
Recent BFRG coverage spans financial news, insider activity and corporate actions.
In the last 30 days, BFRG insiders filed 2 SEC Form 4 transactions — 2 purchases ($71K) and no sales. The most active reporter was Singh Vininder, Chief Executive Officer, with 1 filing.
Small insider purchase signals confidence but limited price impact.
Insider purchase may signal confidence, modest upside potential.
Board compensation committee approved higher CEO pay and a higher target bonus, plus director election and auditor ratification at the annual meeting.
Leadership expansion is a positive commercial-readiness signal, but it is not tied to new revenue, contracts, or clinical milestones.
Bullfrog AI Holdings Inc. (BFRG) experienced a significant stock price increase (>152%) following a strategic partnership with a major pharmaceutical company, leveraging AI for drug discovery in depression treatment. The news indicates positive sentiment and potential for sustained growth if collaboration progresses successfully.
AlphAI scores every news story that mentions BFRG with an AI model for sentiment and relevance, and aggregates insider trades from BullFrog AI Holdings, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Blacher Joshua (Chief Financial Officer) purchased 50,000 shares of BullFrog AI Holdings, Inc. (BFRG) at $0.53 on 2026-09-22.
1 min readSingh Vininder (Chief Executive Officer) purchased 75,000 shares of BullFrog AI Holdings, Inc. (BFRG) at $0.60 on 2026-09-22.
1 min readBullFrog AI Holdings, Inc. (BFRG) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. false 0001829247 0001829247 2026-06-11 2026-06-11 0001829247 BFRG:CommonStockParValue0.00001Member 2026-06-11 2026-06-11 0001829247 BFRG:TradeableWarrantsMember 2026-06-11 2026-06-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSIO
3 min readBullFrog AI Holdings (NASDAQ: BFRG; BFRGW) said it appointed John Stewart as SVP Commercial Sales, Eric Roos as SVP Business Development & Corporate Strategy, and Tom Hazel, Ph.D., as VP Scientific Operations to execute its growth strategy for its integrated pharma AI platform. The company said the team will expand its commercial pipeline and partnerships across bfPREP, bfLEAP and bfARENAS.
4 min readBullfrog AI Holdings Inc. (BFRG) shares surged over 152% after announcing an agreement with a major global pharmaceutical company. This collaboration will utilize Bullfrog AI's bfLEAP program to identify and prioritize novel drug targets for major depressive disorder (MDD), aiming to accelerate drug discovery and clinical development. CEO Vin Singh views the agreement as a validation of Bullfrog AI's capabilities and anticipates expanding the partnership into other R&D areas.
2 min readRedChip Companies will broadcast interviews with BullFrog AI, Inc. (Nasdaq:BFRG) and Myriad Uranium Corp. (OCTQB:MYRUF) on its "RedChip Small Stocks, Big Money™" show on Bloomberg TV this Saturday, November 29, at 7 p.m. ET. BullFrog AI's CEO will discuss their AI-driven drug development platform, highlighting recent milestones and growth potential in the biopharma R&D market. Myriad Uranium's CEO will outline the company's strategy for advancing its Copper Mountain and Red Basin uranium projects, emphasizing their significant resource estimates and market positioning amid increasing global demand for uranium.
2 min readNew publication details how BullFrog Data Networks® and bfLEAP® technology address fundamental AI challenges in drug discovery and development New publication details how BullFrog Data Networks® and bfLEAP® technology address fundamental AI challenges in drug discovery and development ...
3 min readGAITHERSBURG, Md., Sept. 08, 2025 ( GLOBE NEWSWIRE ) -- BullFrog AI Holdings, Inc.
2 min readGAITHERSBURG, Md., July 28, 2025 ( GLOBE NEWSWIRE ) -- BullFrog AI Holdings, Inc. ( NASDAQ: BFRG. BFRGW ) ( "BullFrog AI" or the "Company" ) , a technology-enabled drug development company using artificial intelligence ( "AI" ) and machine learning to enable the successful development of ...
2 min readFrom target discovery to trial optimization, bfLEAP™ empowers biopharma teams to predict therapeutic success with greater confidence ...
3 min read